期刊
SCIENCE CHINA-LIFE SCIENCES
卷 60, 期 5, 页码 468-475出版社
SCIENCE PRESS
DOI: 10.1007/s11427-017-9057-2
关键词
CRISPR/Cas9; gene therapy; in vivo; ex vivo
类别
资金
- National Natural Science Foundation of China [31371455, 31171318, 81330049]
- Science and Technology Commission of Shanghai Municipality [14140900300]
CRISPR/Cas9 is a versatile genome-editing tool which is widely used for modifying the genome of both prokaryotic and eukaryotic organisms for basic research and applications. An increasing number of reports have demonstrated that CRISPR/Cas9-mediated genome editing is a powerful technology for gene therapy. Here, we review the recent advances in CRISPR/Cas9-mediated gene therapy in animal models via different strategies and discuss the challenges as well as future prospects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据